Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 14 of 14
Full-Text Articles in Medicine and Health Sciences
Oncolog, Volume 63, Number 08, August 2018, Angie N. Meus, Joe Munch, Bryan Tutt
Oncolog, Volume 63, Number 08, August 2018, Angie N. Meus, Joe Munch, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- High-Dose Radiation Therapy for Pancreatic Cancer: trial tests whether radiomodulating agent GC4419 can enable higher doses of stereotactic body radiation therapy
- Image-Guided Cordotomy for Cancer Pain: Computed tomography-guided cordotomy relieves cancer-related refractory pain
- Esophageal, Pharyngoesophageal Reconstruction: Advanced surgical techniques restore digestive continuity
- Therapy Preserves Swallowing Function: New trial tests different swallowing therapy regimens for head and neck cancer patients undergoing radiation therapy
- OncoLog Says Farewell
Oncolog, Volume 62, Number 05-06, May - June 2017, Joe Munch, Bryan Tutt, Kathryn Hale
Oncolog, Volume 62, Number 05-06, May - June 2017, Joe Munch, Bryan Tutt, Kathryn Hale
OncoLog MD Anderson's Report to Physicians (All issues)
- Chimeric Antigen Receptor-Directed Natural Killer Cells for B Cell Malignancies: New take on an experimental therapy holds promise for patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, other lymphoid cancers.
- Preoperative Exercise Program for Pancreatic Cancer Patients: Prehabilitation regimen to improve functional status during chemotherapy evaluated in clinical trials.
- Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer: Clinical Trial will evaluate immune checkpoint inhibitors in patients with operable early-stage disease.
- HOUSE CALL: Genetic Screening for Hereditary Cancer Syndromes: Genetic counseling, testing help people assess, manage cancer risk
Oncolog, Volume 61, Number 09, September 2016, Jill Delsigne-Russell, Brandon C. Strubberg, E Nielsen
Oncolog, Volume 61, Number 09, September 2016, Jill Delsigne-Russell, Brandon C. Strubberg, E Nielsen
OncoLog MD Anderson's Report to Physicians (All issues)
- Transport Oncophysics Could Guide Pancreatic Cancer Treatment: Pancreatic ductal adenocarcinomas respond poorly to standard treatments. Researchers at The University of Texas MD Anderson Cancer Center are applying the principles of physics to characterize the tumors, and these analyses could lead to individualized therapy.
- Nivolumab Shows Potential in Treating Squamous Cell Carcinoma of the Anal Canal: Currently, there are no standard therapy options for patients with treatment-refractory metastatic squamous cell carcinoma of the anal canal (SCCA), but early results of a multi-institutional clinical trial (No. NCI9673) led by researchers at The University of Texas MD Anderson Cancer Center show that the …
Oncolog, Volume 60, Number 08, August 2015, Stephanie Deming, Bryan Tutt, K. Nair
Oncolog, Volume 60, Number 08, August 2015, Stephanie Deming, Bryan Tutt, K. Nair
OncoLog MD Anderson's Report to Physicians (All issues)
- New Gene Therapy for Bladder Cancer Shows Promise: A gene therapy that stimulates interferon production within the body may prove to be effective against high-risk, early-stage bladder cancer when standard treatment fails.
- Vaccine Helps T Cells Target Sarcomas, Melanomas and other Tumors: A vaccine that delivers an antigen to dendritic cells, in turn activating killer T cells that can target specific cancers, is the subject of two ongoing clinical trials,
- INBRIEF: Glypican-1 Shows Promise as a Biomarker for Pancreatic Cancer/Stereotactic Ablative Radiation Therapy for Stage I Non-Small Cell Lung Cancer May Offer Survival Benefit
- HOUSE CALL: Prostate Cancer Screening-Who should …
Oncolog, Volume 59, Number 05, May 2014, Bryan Tutt, Therese Bevers, Zach Bohannan
Oncolog, Volume 59, Number 05, May 2014, Bryan Tutt, Therese Bevers, Zach Bohannan
OncoLog MD Anderson's Report to Physicians (All issues)
- New Treatments may Improve Outcomes for AL Amyloidosis Patients: AL amyloidosis-a rare, potentially fatal disease-has no approved treatments. The ''standard'' treatments are prescribed off-label, and few clinical trials have compared their effectiveness
- Dialog: Screening Mammography Reduces Breast Cancer-Related deaths
- 'Sleeping Beauty'' Technique Modifies T Cells to Treat B Cell Malignancies: A novel technique that helps the patient's own immune system find and destroy cancer cells could extend remission times for patients with B cell lymphomas and leukemias
- INBRIEF: Analysis Suggests Need to Revise Low-Grade Glioma Classification, Treatment/Combination of Antiangiogenic Drugs Shows Activity Against Solid Tumors/ Computed Tomography Predicts Chemotherapy Response …
Oncolog, Volume 58, Number 10, October 2013, Bryan Tutt, Sunni Hosemann, C. Wilcox
Oncolog, Volume 58, Number 10, October 2013, Bryan Tutt, Sunni Hosemann, C. Wilcox
OncoLog MD Anderson's Report to Physicians (All issues)
- Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer May replace Axillary Dissection for Some Patients: Sentinel lymph node dissection has become a standard staging tool for breast cancer patients with no clinical eveidence of disease in the lymph nodes
- INBRIEF: miR-200 MicroRNAs Slow Tumor Growth
- Compass: Resectable or Borderline Resectable Pancreatic Adenocarcinoma: Initial Treatment Options-Neoadjuvent chemoradiation may benefit patients with resectable disease
- HOUSE CALL: Hereditary Cancers: Genetic screening can give valuable information
Oncolog Volume 54, Number 10, October 2009, John Lebas, Bryan Tutt
Oncolog Volume 54, Number 10, October 2009, John Lebas, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Early Testicular Cancer
- Metastatic Rectal Cancer
- House Call: What Is Pancreatic Cancer?
Oncolog Volume 54, Number 05, May 2009, John Lebas
Oncolog Volume 54, Number 05, May 2009, John Lebas
OncoLog MD Anderson's Report to Physicians (All issues)
- Targeting Inflammation in Cancer Prevention
- Treating Radiation Necrosis of the Brain
- Preclinical Studies Reveal Effectiveness of Therapies for Pediatric Cancers
- House Call: Protect and Check Your Skin
Oncolog Volume 53, Number 10, October 2008, Joe Munch, Sunita Patterson
Oncolog Volume 53, Number 10, October 2008, Joe Munch, Sunita Patterson
OncoLog MD Anderson's Report to Physicians (All issues)
- Pancreatic Cancer: The Prognosis Is Changing
- Delivering “The Guardian of the Genome”
- House Call: “Seeing” Cancer from the Outside
- Catching Pancreatic Cancer Early
Oncolog, Volume 52, Number 11, November 2007, Diane Witter, Karen Stuyck, Garth Powis Dphil
Oncolog, Volume 52, Number 11, November 2007, Diane Witter, Karen Stuyck, Garth Powis Dphil
OncoLog MD Anderson's Report to Physicians (All issues)
- Outsmarting Brain Cancer
- Protecting the Heart
- House Call: Recognize the Signs of Ovarian Cancer
- DiaLog: Advancing Drug Design in Academia, by Garth Powis, DPhil, Director, Center for Targeted Therapy, Chair, Department of Experimental Therapeutics
Oncolog, Volume 52, Number 02, February 2007, Diane Witter
Oncolog, Volume 52, Number 02, February 2007, Diane Witter
OncoLog MD Anderson's Report to Physicians (All issues)
- New Findings on Aspirin and Heart Attacks
- Kicking Off a Trend: Cancer-Related Deaths Decline
- House Call: Working Out How to Lower Your Risk of Cancer
Oncolog Volume 51, Number 07/08, July/August 2006, Diane Witter, Sunni Hosemann, Elihu Estey Md
Oncolog Volume 51, Number 07/08, July/August 2006, Diane Witter, Sunni Hosemann, Elihu Estey Md
OncoLog MD Anderson's Report to Physicians (All issues)
- Gaining Momentum in MDS
- When Bone Marrow Goes Awry
- Pancreatic Cancer: It Takes a Village
- House Call: Tired of Being Tired
- DiaLog: Anemia in the Elderly, by Elihu Estey, MD, Professor, Department of Leukemia
Oncolog, Volume 44, Number 04, April 1999, Dawn Chalaire
Oncolog, Volume 44, Number 04, April 1999, Dawn Chalaire
OncoLog MD Anderson's Report to Physicians (All issues)
- Pancreatic Tumor Team Studies Disease Mechanisms, Reverses Conventional Approach
- Patient Helps Underwrite Familial Cancer Study
- Stomach Cancer Protocols Offer Options
- Gastric Cancer's Low Survival Rate and High Relapse Rate Challenge Physicians
- House Call: Environmental Carcinogens: Fact and Fiction
- Protocols: Pancreatic Cancer Protocol Options Include Gemdtabine and Marimastat
Oncolog, Volume 36, Issue 02, April-June 1991, Gilbert H. Fletcher M.D., James M. Bowen
Oncolog, Volume 36, Issue 02, April-June 1991, Gilbert H. Fletcher M.D., James M. Bowen
OncoLog MD Anderson's Report to Physicians (All issues)
- Redefining the risks of chemotherapy during pregnancy Renewing the assault on pancreatic cancer
- Significance of cancer volume in radiotherapy